![]() | ![]() |
|
|
| | Investors Home | Management Team | Board of Directors | Events Calendar | SEC Filings | Financial Statements | FAQ | |
Download Corporate Profile |
|
Frequently Asked Questions about ZIOPHARM Oncology, Inc. Q: On which exchange is ZIOPHARM Oncology, Inc. traded? A: We are eligible for trading on the Over-the-Counter Bulletin Board (also referred to as the OTCBB). Q: What is ZIOPHARM Oncology's ticker symbol? A: The ticker symbol under which we trade is "ZIOP.OB." Q: When did the company commence operations? A: ZIOPHARM, Inc., our private company predecessor, commenced operations in January 2004. In September 2005, ZIOPHARM, Inc. merged with a public reporting company named EasyWeb Inc. to form ZIOPHARM Oncology, Inc. Q: Where is ZIOPHARM Oncology located? A: Our executive headquarters are located at 1180 Avenue of the Americas, 19th Floor, New York, NY 10036. Our operations office is located in Charlestown, MA. Q: When did ZIOPHARM Oncology "go public?" A: In September 2005, ZIOPHARM, Inc. merged with a public reporting company named EasyWeb Inc. to form ZIOPHARM Oncology, Inc. Following the merger, ZIOPHARM Oncology, Inc. remains a public reporting company. Q: Who is ZIOPHARM Oncology's transfer agent? A: ZIOPHARM Oncology’s transfer agent is: American Stock Transfer & Trust Company 6201 15th Avenue, Brooklyn, New York 11219 Attn: Shareholder Services 1-877-248-6417 or 1-718-921-8317 Q: How do I make changes to, or find out information about, my stock certificate? A: Please contact our transfer agent (as above). Q: How can I replace my lost stock certificates? A: Contact our transfer agent (as above) Q: Can I purchase shares of ZIOPHARM Oncology stock directly from the company? A: No. ZIOPHARM Oncology does not currently have a direct stock purchase plan and is not offering to sell shares of its stock to the public. Q: Who are the members of the Board of Directors and executive management? Who is on the Medical Advisory Board? A: For more information about our directors, members of our management and members of our Medical Advisory Board, please click here: Board of Directors Medical Advisory Board Management Q: When does the company's fiscal year end? A: Our fiscal year coincides with the calendar year. As a result, our fiscal year end is December 31st each year. Q: How can I get information on healthcare conferences ZIOPHARM Oncology participates in? A: Please visit the Investor Relations pages under events. Please click here Q: How can I get news updates concerning ZIOPHARM Oncology? A: Please click here to be directed to the information requests page. Q: Has ZIOPHARM Oncology done a stock split? A: ZIOPHARM, Inc. effected a 1 for 4 reverse stock split in March 2004 and EasyWeb, Inc. effected a 1 for 40 reverse stock split in August 2005. In connection with the September 2005 merger transaction, each outstanding share of ZIOPHARM, Inc. was exchanged for approximately 0.500974 shares of ZIOPHARM Oncology. Shares of EasyWeb, Inc. common stock outstanding at the time of the merger transaction were not affected by this exchange ratio. We have not declared any stock splits since our September 2005 merger transaction. | Businessweek article July 23, 2007 issue More Businessweek article May 5, 2008 issue More Forbes.com article May 9, 2008 issue More ZIO-101 listed as 100 Great Investigational Drugs by R&D Directions More ZIO-201 listed as 100 Great Investigational Drugs by R&D Directions More Robert W. Baird 2006 Focus on Oncology Conference August 2, 2006 New York, NY Click here for Webcast Click here for Presentation Wall Street Analyst Forum June 14, 2006 New York, NY Click here for Webcast Click here for Presentation ASCO June 2-6, 2006 Atlanta, GA Click here for Presentation Information Request Investor Kit Click to receive news alerts |
|
|